Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This entry most plausibly refers to a **combination injection kit** built around **dexamethasone sodium phosphate** as the therapeutically active corticosteroid, with **povidone-iodine** and **isopropyl alcohol** serving as topical antiseptic skin-preparation components packaged with the product rather than contributing the main systemic therapeutic effect. Mechanistically, dexamethasone sodium phosphate is a **small-molecule synthetic glucocorticoid receptor agonist** that suppresses inflammatory gene expression and broad immune activation, consistent with the wide set of labeled corticosteroid indications in the provided text, including endocrine, rheumatologic, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and cerebral edema settings. However, the exact string **\"povidone-iodine + isopropyl alcohol + dexamethasone sodium\"** does not map cleanly to a uniquely identifiable marketed brand in the provided material, so this annotation treats it as a non-specific combination product concept centered on injectable dexamethasone sodium phosphate rather than a firmly established distinct brand asset.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on povidone-iodine + isopropyl alcohol + dexamethasone sodium.